AmCAD-UO
Overview
AmCAD-UO is an innovative, AI-powered ultrasound solution developed by AmCad BioMed Corporation, designed to assist physicians in the evaluation and monitoring of Obstructive Sleep Apnea (OSA) syndrome. The system comprises a precise positioning system and a computer-assisted detection (CAD) software device. The software then automatically detects the airspace of the pharyngeal airway and computes dynamic changes to assess the risk of OSA. This non-invasive evaluation process is performed on awake patients and delivers results in approximately 10 minutes, offering an objective, accurate, cost-effective, and safe approach to OSA diagnosis.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered ultrasound analysis for Obstructive Sleep Apnea (OSA)
- Non-invasive upper airway scanning
- Computer-assisted detection (CAD) software
- Automatic detection of pharyngeal airway airspace
- Dynamic change computation of airspace for OSA risk evaluation
- 10-minute assessment on awake patients
- Objective, accurate, cost-effective, and safe evaluation process
- Laser-guided positioning for precise scanning
- 3D anatomic airway assessment
- Standardizes ultrasound transducer scanning to reduce intra-observer variations
Use Cases
- Evaluating the risk of Obstructive Sleep Apnea (OSA) syndrome
- Assessing moderate/severe OSA patients
- Identifying the root cause of sleep apnea
- Evaluating patients for tongue reduction surgery (ENT)
- Assessing the effectiveness of oral appliances in dentistry
- Precision treatment and follow-up in clinical settings for OSA
What Physicians Need to Know
AmCAD-UO provides a rapid, non-invasive ultrasound-based assessment for Obstructive Sleep Apnea (OSA) in awake patients, offering a valuable screening tool to identify at-risk individuals. The AI-powered analysis helps pinpoint potential collapse areas in the upper airway, providing objective measurements. This can be particularly useful for initial risk assessment, monitoring treatment progress, and in settings where traditional polysomnography is not readily available or feasible. The system's ability to provide consistent, trackable evaluations through laser-guided positioning can aid in longitudinal patient management. It can also assist in predicting the suitability of patients for certain therapies like hypoglossal nerve stimulation.
The AmCAD-UO system is compatible with all ultrasound systems, transferring images to a Windows-based computer for AI analysis and report generation. While direct PACS integration details for AmCAD-UO are not explicitly detailed, AmCAD BioMed's other AI solutions are designed to integrate with radiology workstations and PACS, suggesting a similar capability or potential for AmCAD-UO. The system's output of a detection report can be incorporated into existing electronic health record systems.
Details
| Category | Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | PC based, self contained system; Images are transferred from the ultrasound machine to a Windows-based computer for analysis. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Otolaryngology (ENT), Radiology, Sleep Medicine |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2018-12-28 | K180867 510(k) | AmCAD-UO |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate AmCAD-UO
Videos
Product demos, reviews, and walkthroughs for AmCAD-UO.
AmCAD - US
AmCadBioMed






